Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: August 1, 2019; Last Reviewed: August 1, 2019
|Bolan, Gail||Centers for Disease Control and Prevention||None||N/A|
|Ghanem, Khalil||Johns Hopkins University||None||N/A|
|Hollier, Lisa||Baylor College of Medicine||None||N/A|
|Hook, Edward W.
||University of Alabama at Birmingham
||National Institutes of Health||Research Support|
|Sena, Arlene||University of North Carolina||Gilead Sciences||Research Support|
||Speaking Compensation, Advisory Board
|Lupin Pharmaceuticals, Inc||Research Support|
|Stoner, Brad||Washington University School of Medicine||None||N/A|
|Workowski, Kim*||Emory University||Acuris||Research Support|
|Gilead Sciences||Advisory Board, Research Support|
|GlaxoSmithKline||Advisory Board, Research Support|
|Janssen Pharmaceuticals||Advisory Board|
* Group lead
Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive